Further to this, GLP‐1 therapy has also been shown to augment anti‐inflammatory and anti‐atherosclerotic processes, demonstrated by their ability to reduce occurrence of myocardial infarctions and strokes (Tanaka & Node, 2018). This evidence concerns the gene GLP1R and Stroke.